AKTUELLE RHEUMATOLOGIE

Scope & Guideline

Uncovering the latest breakthroughs in rheumatic care.

Introduction

Immerse yourself in the scholarly insights of AKTUELLE RHEUMATOLOGIE with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageMulti-Language
ISSN0341-051x
PublisherGEORG THIEME VERLAG KG
Support Open AccessNo
CountryGermany
TypeJournal
Convergefrom 1978 to 2024
AbbreviationAKTUEL RHEUMATOL / Aktuelle Rheumatol.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRUDIGERSTR 14, D-70469 STUTTGART, GERMANY

Aims and Scopes

AKTUELLE RHEUMATOLOGIE focuses on advancing the understanding and treatment of rheumatic diseases through rigorous research and clinical studies. The journal encompasses a broad spectrum of topics related to rheumatology, including pathophysiology, treatment modalities, and patient management strategies.
  1. Exploration of Disease Mechanisms:
    The journal emphasizes research that investigates the underlying mechanisms of various rheumatic diseases, aiming to uncover novel pathophysiological insights that can inform treatment strategies.
  2. Clinical Trials and Treatment Efficacy:
    AKTUELLE RHEUMATOLOGIE publishes studies evaluating the efficacy and safety of new and existing therapies for rheumatic conditions, including biologics and traditional disease-modifying antirheumatic drugs (DMARDs).
  3. Patient-Centered Research:
    The journal features research on patient outcomes, quality of life, and the psychosocial aspects of living with rheumatic diseases, highlighting the importance of patient perspectives in clinical practice.
  4. Comorbidities and Risk Factors:
    Research on the comorbidities associated with rheumatic diseases, including cardiovascular risks and mental health issues, is a core focus, emphasizing the need for comprehensive care approaches.
  5. Innovative Diagnostic Approaches:
    The journal encourages studies that advance diagnostic methods, including imaging techniques and biomarkers, to improve early detection and monitoring of rheumatic diseases.
  6. Interdisciplinary Collaboration:
    AKTUELLE RHEUMATOLOGIE promotes interdisciplinary approaches, integrating insights from various medical fields to enhance the management of rheumatic diseases.
Recent publications in AKTUELLE RHEUMATOLOGIE indicate several emerging themes that reflect the evolving landscape of rheumatology research. These trends highlight the journal's responsiveness to contemporary challenges in the field.
  1. Telemedicine and Digital Health:
    There is a notable increase in studies exploring telemedicine and digital health interventions, particularly in response to the COVID-19 pandemic, emphasizing their role in enhancing patient care and accessibility.
  2. Microbiome Research in Rheumatology:
    An emerging focus on the relationship between the microbiome and rheumatic diseases is evident, with research investigating how gut health may influence disease activity and treatment responses.
  3. Gender Differences in Rheumatic Diseases:
    Recent papers are increasingly addressing the impact of gender on disease presentation, treatment efficacy, and outcomes, acknowledging the necessity of gender-sensitive approaches in rheumatology.
  4. Personalized Medicine and Biomarkers:
    Research on personalized medicine, including the identification of biomarkers for predicting disease progression and treatment responses, is gaining traction, reflecting a shift towards individualized patient care.
  5. Socioeconomic Factors in Disease Management:
    There is a growing interest in understanding how socioeconomic factors affect disease management, treatment adherence, and health outcomes in patients with rheumatic diseases.

Declining or Waning

While AKTUELLE RHEUMATOLOGIE continues to thrive in several research areas, some themes have seen a decline in focus over recent years. This section highlights those diminishing topics.
  1. Traditional Treatment Modalities:
    Research on conventional therapies, such as older DMARDs, appears to be waning as the field shifts towards biologics and targeted therapies, reflecting a growing emphasis on innovative treatment options.
  2. Historical Perspectives:
    Papers focusing on the historical aspects of rheumatology, while still valuable, are becoming less frequent as contemporary clinical research takes precedence in the journal's publications.
  3. Generalized Pain Management Strategies:
    Studies that provide broad, non-specific pain management strategies are declining in favor of more tailored, disease-specific approaches that address the unique needs of patients with rheumatic diseases.
  4. Basic Science Research:
    There seems to be a diminishing interest in purely basic science research without direct clinical implications, as the journal increasingly prioritizes studies that bridge the gap between laboratory findings and clinical application.

Similar Journals

Archives of Rheumatology

Advancing knowledge in rheumatology for a healthier future.
Publisher: TURKISH LEAGUE AGAINST RHEUMATISMISSN: Frequency: 4 issues/year

Archives of Rheumatology is a premier peer-reviewed journal dedicated to advancing the field of rheumatology through the dissemination of high-quality research, reviews, and case studies. Published by the Turkish League Against Rheumatism, this open-access journal provides a platform for researchers, clinicians, and students to share insightful findings and innovative approaches in the diagnosis and management of rheumatologic diseases. With the goal of promoting knowledge exchange on a global scale, the journal welcomes submissions that enhance understanding and foster advancements in the clinical and biological aspects of rheumatic conditions. Each publication contributes significantly to the growing body of literature in this vital field of medicine, making Archives of Rheumatology an essential resource for both established and emerging researchers looking to stay abreast of the latest developments and clinical practices.

Acta Reumatologica Portuguesa

Connecting professionals to groundbreaking rheumatic research.
Publisher: PUBLISAUDE-EDICOES MEDICAS LDAISSN: 0303-464XFrequency: 4 issues/year

Acta Reumatologica Portuguesa is a premier open access journal dedicated to the field of rheumatology and general medicine, published by PUBLISAUDE-EDICOES MEDICAS LDA since its inception in 1973. Situated in Portugal, this journal aims to disseminate high-quality research findings, clinical studies, and reviews that contribute to the understanding and management of rheumatic diseases. Despite its current Q4 ranking in both Medicine (miscellaneous) and Rheumatology, it serves as a vital platform for researchers and professionals aiming to share innovative insights and clinical practices within a rapidly evolving field. Researchers and medical professionals will find valuable information that can significantly influence their work, given the journal’s commitment to accessible knowledge through its open access model. By prioritizing collaboration and knowledge-sharing, Acta Reumatologica Portuguesa continues to engage with issues of critical relevance in rheumatology, appealing to a diverse audience of scholars and healthcare practitioners.

Reumatologia Clinica

Empowering insights into rheumatic diseases.
Publisher: ELSEVIER ESPANA SLUISSN: 1699-258XFrequency: 6 issues/year

Reumatologia Clinica is a distinguished journal dedicated to the field of Rheumatology, published by Elsevier España SLU. With its ISSN of 1699-258X and E-ISSN 1885-1398, the journal aims to disseminate pivotal research findings and clinical studies from 2005 to 2024, spotlighting advancements in the understanding and treatment of rheumatic diseases. Based in Barcelona, Spain, it plays a vital role in the academic community, ranking in the Q3 category for Rheumatology as of 2023, with a Scopus ranking of #44 out of 73, placing it in the 40th percentile. Although it operates under a traditional access model, the journal is committed to academic excellence, providing researchers, healthcare professionals, and students with invaluable insights that drive the field forward. Reumatologia Clinica serves as an essential resource for those looking to deepen their knowledge and contribute to the evolving landscape of rheumatologic research.

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

Transforming clinical practice with authoritative knowledge.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0889-857XFrequency: 4 issues/year

Rheumatic Disease Clinics of North America is a premier journal published by W B Saunders Co-Elsevier Inc, dedicated to advancing the field of rheumatology through comprehensive and impactful research. With an ISSN of 0889-857X and an E-ISSN of 1558-3163, this esteemed publication has been disseminating knowledge since its inception in 1987, and continues to guide clinicians and researchers alike through its insightful articles and case studies. Positioned in the 2023 Q2 quartile for Rheumatology, it ranks #31 out of 73 journals in the Scopus category of Medicine _ Rheumatology, reflecting a commendable impact factor and relevance in the academic community. Although it does not offer open access options, the journal ensures that subscribers have access to cutting-edge research and reviews that address contemporary challenges and advancements in rheumatic disease. With its authoritative content, Rheumatic Disease Clinics of North America serves as a vital resource for those striving to improve patient care and clinical outcomes in the ever-evolving landscape of rheumatology research.

International Journal of Rheumatic Diseases

Elevating the discourse on rheumatology.
Publisher: WILEYISSN: 1756-1841Frequency: 12 issues/year

The International Journal of Rheumatic Diseases, published by WILEY, serves as a crucial platform for disseminating high-quality research and advancements in the field of rheumatology. With an ISSN of 1756-1841 and an E-ISSN of 1756-185X, this journal has established itself within the academic community since its inception in 2008, and it is set to continue until at least 2024. Positioned in the Q3 category of rheumatology, the journal holds a significant rank of #38 out of 73 in its field according to Scopus, showcasing its growing influence despite the competitive environment. The absence of Open Access reflects a traditional scholarly publishing model, allowing for meticulous peer-review processes to ensure the rigor and reliability of published studies. This journal aims to foster innovative research, critical reviews, and clinical studies, thereby contributing to a deeper understanding of rheumatic diseases and enhancing patient care. The dedicated readership, including researchers, healthcare professionals, and students, will find valuable insights into the latest findings and methodologies relevant to rheumatology in the journal's comprehensive articles.

Arthritis & Rheumatology

Advancing Knowledge in Rheumatology and Immunology
Publisher: WILEYISSN: 2326-5191Frequency: 12 issues/year

Arthritis & Rheumatology is a leading journal dedicated to the advancement of knowledge in the fields of rheumatology, immunology, and allergy. Published by WILEY in the United Kingdom, this prestigious journal boasts an impressive impact factor and a prominent reputation, ranking in the Q1 category across multiple disciplines, including Immunology and Rheumatology. With its high ranking of 4th out of 73 in Rheumatology and notable standings in related fields, it serves as a crucial platform for researchers, healthcare professionals, and scholars to disseminate groundbreaking findings. The journal embraces an Open Access model, enhancing the accessibility of vital research to a global audience and ensuring that knowledge dissemination is maximized. Since its inception in 2014, Arthritis & Rheumatology has been at the forefront of impactful research, fostering collaboration and innovation in tackling complex challenges within these medical disciplines. Researchers looking to explore the latest advancements and engage with cutting-edge studies in these fields will find this journal to be an essential resource.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

Empowering Professionals Through Cutting-edge Research
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1076-1608Frequency: 8 issues/year

JCR-Journal of Clinical Rheumatology, published by Lippincott Williams & Wilkins, is a premier outlet dedicated to the field of rheumatology, recognized for its contributions and relevance among medical journals. Boasting an impact factor reflective of its vital role in disseminating innovative research, it currently holds a Q2 category ranking in Medicine (miscellaneous) and a Q3 ranking in Rheumatology as of 2023. With its convergence years spanning from 1995 to 2024, the journal aims to foster the advancement of knowledge in clinical practices, therapeutic advances, and patient management strategies concerning rheumatic diseases. Researchers, professionals, and students can access a wealth of benchmark studies and peer-reviewed articles, enhancing their understanding and collaboration within this dynamic field. By bridging clinical insights with rigorous research, the JCR-Journal of Clinical Rheumatology remains an important resource for advancing the understanding of rheumatologic disorders and improving patient care.

Egyptian Rheumatologist

Championing excellence in rheumatology studies.
Publisher: ELSEVIERISSN: 1110-1164Frequency: 4 issues/year

The Egyptian Rheumatologist is a peer-reviewed Open Access journal dedicated to advancing the field of rheumatology. Published by Elsevier since 2011, the journal aims to disseminate high-quality research, clinical innovations, and reviews that cover a wide range of topics related to autoimmune diseases, arthritis, and musculoskeletal disorders. With an ISSN of 1110-1164 and an E-ISSN of 2090-2433, it has achieved a respectable rank of #50 out of 73 in the medicine/rheumatology category according to Scopus, positioning it in the 32nd percentile among its peers. Operating from its base in Amsterdam, Netherlands, the journal provides an accessible platform for researchers, professionals, and students, encouraging a collaborative exchange of cutting-edge knowledge that is essential for the ongoing developments in rheumatologic care and research. The Open Access model ensures that critical findings and advancements are available to a global audience, fostering further research and education within this vital field.

Current Rheumatology Reviews

Exploring breakthroughs in rheumatology advancements.
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1573-3971Frequency: 3 issues/year

Current Rheumatology Reviews is an esteemed journal dedicated to publishing comprehensive reviews on advancements in the field of rheumatology. Established by Bentham Science Publishers, this journal has become a vital resource for researchers, clinicians, and students seeking to stay abreast of the latest developments and therapeutic strategies from 2006 to 2024. Located in the United Arab Emirates, it caters to a global audience, delivering insights that have been pivotal in shaping clinical practices. With an impact factor reflective of its Q3 status in Rheumatology by 2023, the journal ranks #46 out of 73 in the Scopus database, positioning it in the 37th percentile in the discipline. Although it operates without open access, its high-quality content ensures that each article undergoes rigorous peer review, making the Current Rheumatology Reviews a trusted platform for disseminating critical research findings and reviews that drive forward the understanding and treatment of rheumatic diseases.

Reumatologia

Fostering collaboration in the fields of Immunology and Rheumatology.
Publisher: TERMEDIA PUBLISHING HOUSE LTDISSN: 0034-6233Frequency: 6 issues/year

Reumatologia is a dedicated open-access journal published by TERMEDIA PUBLISHING HOUSE LTD that has been serving the global scientific community since 2005. The journal focuses on the fields of Rheumatology, Immunology, and Allergy, providing a rich platform for researchers and practitioners to share innovative findings, clinical insights, and methodologies. With its roots tracing back to the early 1960s and a steady convergence of quality content through 2024, Reumatologia has secured a place in the academic landscape, currently holding a Q4 rating in Immunology and a Q3 rating in both Immunology and Allergy and Rheumatology categories for 2023. While the journal ranks #42 out of 73 in the Medicine - Rheumatology category, its open-access model ensures that research is widely disseminated, enhancing visibility and accessibility to vital knowledge that shapes therapeutic practices. Located in Poznan, Poland, Reumatologia remains a pivotal source of credible research, fostering collaboration among academics, healthcare professionals, and students internationally.